October 7, 2026 Type 1 diabetes briefing: trials, device safety, and research signals
A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.
The short version
The October 7, 2026 feed is strongest in three lanes: device safety, recruiting studies, and recent research records. Type1Cure treats safety and trial records as higher-priority signals because they can affect what a family may need to check, ask, or watch next.
This is not a medical recommendation. It is a source map and plain-English triage layer designed to help families decide what deserves a closer look with their care team.
Signals in the feed
- Tandem Diabetes Care, Inc.: Brand Name: Tandem t:slim mobile application Product Name: t:slim Mobile Application, iOS Model/Catalog Number: iOS software version 2.13 Software Version: iOS software version 2.... — A beta (early-release) version of the iOS application, version 2.13 (TestFlight) had a software issue preventing successful pairing of the t:slim application with Abbott FreeStyle Libre 3 Plus (FSL3P) continuous glucose...Source
- Acute Metabolic Effects of Tirzepatide in Type 1 Diabetes — RECRUITING, PHASE2. Interventions: Tirzepatide 2.5mg weekly, Placebo injection (normal saline). Locations: Sydney, New South Wales, Australia. This study will examine the effects of Tirzepatide (TZP), a glucagon-like pe...Source
- Effect of Different Carbohydrate Intake Patterns on Glycemic Control in Patients With Type 1 Diabetes — RECRUITING, NA. Interventions: diverse carbohydrate diet, moderate carbohydrate diet. Locations: Nanjing, Jiangsu, China. This multicenter, randomized, controlled, open-label clinical trial aims to evaluate the effects...Source
- Making Diabetes Care Fit for Young Adults Living With Type 1 Diabetes: Observations, Reflections and Expert Opinions — RECRUITING, NA. Interventions: Making Care Fit tool, Care as usual. Locations: Leiden, South Holland, Netherlands | Rotterdam, South Holland, Netherlands. The goal of this clinical study is to assess differences in coll...Source
- The Gut Microbiome in Type 1 Diabetes and Mechanism of Metformin Action — RECRUITING, PHASE2. Interventions: Metformin. Locations: Indianapolis, Indiana, United States. Ovwerweight and obesity prevalence in persons with T1D has increased, which further complicates management and risk for comp...Source
- Medtronic MiniMed, Inc.: MiniMed 640G Insulin Pump, Model: MMT-1711, MMT-1712; — Loaner insulin pumps may have been cleaned with chemically incompatible products that could damage the pump case or keypad, allow moisture ingress, and result in insulin over- or under-delivery, potentially causing hypo...Source
- Medtronic MiniMed, Inc.: MiniMed 670G Insulin Pump, Model: MMT-1781, MMT-1782; — Loaner insulin pumps may have been cleaned with chemically incompatible products that could damage the pump case or keypad, allow moisture ingress, and result in insulin over- or under-delivery, potentially causing hypo...Source
How to use this briefing
Start with the evidence label. Official registry and regulator records are not the same thing as advice, but they are stronger source material than a repost, rumor, or promotional headline.
For trials, check eligibility, location, burden, intervention, and contact details at the original registry. For device safety, check exact product names, models, lot numbers, software versions, and manufacturer instructions.
This article is an evidence-labeled information brief, not medical advice. Use the linked source records and your care team before making treatment decisions.